These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2042208)

  • 1. [Stiffness of the heart--stunning].
    Thaulow E; Nitter-Hauge S
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):938-41. PubMed ID: 2042208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transient coronary occlusion: experience with myocardial stunning and preconditioning.
    Schott RJ; Schaper W
    Isr J Med Sci; 1989 Sep; 25(9):479-82. PubMed ID: 2807863
    [No Abstract]   [Full Text] [Related]  

  • 3. Hibernating myocardium, stunning, ischemic preconditioning: clinical relevance.
    Futterman LG; Lemberg L
    Am J Crit Care; 2000 Nov; 9(6):430-6. PubMed ID: 11072559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.
    Monnet X; Ghaleh B; Colin P; de Curzon OP; Giudicelli JF; Berdeaux A
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1133-9. PubMed ID: 11714904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic myocardial dysfunction during endotoxemia: dependent or independent of myocardial ischemia?
    Adams HR; Parker JL; Laughlin MH
    Circ Shock; 1990 Jan; 30(1):63-76. PubMed ID: 2406037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible myocardial dysfunction after cardiopulmonary resuscitation.
    Ruiz-Bailén M; Aguayo de Hoyos E; Ruiz-Navarro S; Díaz-Castellanos MA; Rucabado-Aguilar L; Gómez-Jiménez FJ; Martínez-Escobar S; Moreno RM; Fierro-Rosón J
    Resuscitation; 2005 Aug; 66(2):175-81. PubMed ID: 16053943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of mechanical dysfunction in regional stunned myocardium of the left ventricle.
    Drzewiecki G; Wang JJ; Li JK; Kedem J; Weiss H
    IEEE Trans Biomed Eng; 1996 Dec; 43(12):1151-63. PubMed ID: 9214834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac decompensation: mechanism of reversibility].
    Melin J; Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1997; 152(1):101-8; discussion 108-11. PubMed ID: 9491624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low osmolality contrast materials on coronary hemodynamics, myocardial function, and coronary sinus osmolality in normal and ischemic states.
    Deutsch AL; Gerber KH; Haigler FH; Higgins CB
    Invest Radiol; 1982; 17(3):284-91. PubMed ID: 7118517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium].
    Sokolova RI; Zhdanov VS
    Arkh Patol; 2002; 64(1):50-4. PubMed ID: 11889704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A disorder of myocardial contractile function in acute experimental coronary failure: the submolecular mechanisms and the action of cardiac glycosides].
    Karsanov NV; Sukoian GV; Tatulashvili DR; Karsanov VN; Guledani NE
    Eksp Klin Farmakol; 2000; 63(2):24-34. PubMed ID: 10834090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation between myocardial contractility and systemic hemodynamics in the early stages of severe blood flow disorders in a major coronary artery].
    Orlova NN
    Biull Eksp Biol Med; 1981 Sep; 92(9):279-81. PubMed ID: 7295980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of intravenous vs. intracoronary nifedipine on myocardial segment function in ischemic canine hearts.
    Lamping KA; Gross GJ
    J Pharmacol Exp Ther; 1984 Jan; 228(1):28-32. PubMed ID: 6694108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method to calculate regional myocardial tension by intramyocardial pressure recording and its application to estimate regional myocardial contractility in ischemic left ventricle].
    Tsuiki K; Oguma M
    Kokyu To Junkan; 1983 Jan; 31(1):73-6. PubMed ID: 6857016
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury.
    Bolli R; Triana F; Jeroudi MO
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization.
    Skyschally A; Haude M; Dörge H; Thielmann M; Duschin A; van de Sand A; Konietzka I; Büchert A; Aker S; Massoudy P; Schulz R; Erbel R; Heusch G
    Circulation; 2004 May; 109(19):2337-42. PubMed ID: 15117838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.